Empagliflozin (EMPA) Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since June 2026

Pipeline

Phase 2: 2

Top Sponsors

Mayo Clinic1
Ain Shams University1

Indications

Pancreatitis, Acute1
Heart Disease1
Pancreatitis, Chronic1
Diabetes Mellitus1
Diabetes1

Other1 trial

the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients

Phase 2

Rochester, Minnesota1 trial

Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus

Mayo Clinic

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.